

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 9.67444591 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.62774036 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.62774036 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.26301955 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.26301955 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.94460292 |
| 7 | drug metabolic process (GO:0017144) | 6.65414003 |
| 8 | oxidative demethylation (GO:0070989) | 6.59434937 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.33152126 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.33152126 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.33152126 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.31751085 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.16614790 |
| 14 | bile acid biosynthetic process (GO:0006699) | 6.04095442 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.94074576 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.72862253 |
| 17 | urea metabolic process (GO:0019627) | 5.72419105 |
| 18 | urea cycle (GO:0000050) | 5.72419105 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.64450079 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.56599668 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.56584711 |
| 22 | ethanol metabolic process (GO:0006067) | 5.51288809 |
| 23 | complement activation, alternative pathway (GO:0006957) | 5.49205508 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.48848930 |
| 25 | regulation of protein activation cascade (GO:2000257) | 5.43994935 |
| 26 | cysteine metabolic process (GO:0006534) | 5.29434646 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 5.26894551 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.24334543 |
| 29 | bile acid metabolic process (GO:0008206) | 5.15549088 |
| 30 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.11436683 |
| 31 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.11436683 |
| 32 | phenylpropanoid metabolic process (GO:0009698) | 5.10600892 |
| 33 | regulation of plasminogen activation (GO:0010755) | 5.10509764 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 5.08504814 |
| 35 | regulation of complement activation (GO:0030449) | 5.07990841 |
| 36 | regulation of humoral immune response (GO:0002920) | 5.03794107 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 5.03322478 |
| 38 | * peptidyl-glutamic acid carboxylation (GO:0017187) | 4.99611000 |
| 39 | * protein carboxylation (GO:0018214) | 4.99611000 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 4.87980661 |
| 41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.87933307 |
| 42 | S-adenosylmethionine metabolic process (GO:0046500) | 4.85097040 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.84741281 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.84526532 |
| 45 | reverse cholesterol transport (GO:0043691) | 4.83356930 |
| 46 | negative regulation of protein activation cascade (GO:2000258) | 4.81427832 |
| 47 | homocysteine metabolic process (GO:0050667) | 4.77568629 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.76933404 |
| 49 | protein-lipid complex remodeling (GO:0034368) | 4.76933404 |
| 50 | macromolecular complex remodeling (GO:0034367) | 4.76933404 |
| 51 | negative regulation of hemostasis (GO:1900047) | 4.76473797 |
| 52 | negative regulation of blood coagulation (GO:0030195) | 4.76473797 |
| 53 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.68782288 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 4.65978578 |
| 55 | acylglycerol homeostasis (GO:0055090) | 4.61777385 |
| 56 | triglyceride homeostasis (GO:0070328) | 4.61777385 |
| 57 | amino-acid betaine metabolic process (GO:0006577) | 4.60216380 |
| 58 | phospholipid efflux (GO:0033700) | 4.58769926 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.55600546 |
| 60 | negative regulation of sterol transport (GO:0032372) | 4.55600546 |
| 61 | lysine metabolic process (GO:0006553) | 4.53491595 |
| 62 | lysine catabolic process (GO:0006554) | 4.53491595 |
| 63 | indolalkylamine metabolic process (GO:0006586) | 4.48156285 |
| 64 | bile acid and bile salt transport (GO:0015721) | 4.46099148 |
| 65 | coenzyme catabolic process (GO:0009109) | 4.45068150 |
| 66 | cellular biogenic amine catabolic process (GO:0042402) | 4.42068029 |
| 67 | amine catabolic process (GO:0009310) | 4.42068029 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.38514300 |
| 69 | glycine metabolic process (GO:0006544) | 4.36266204 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 4.34952623 |
| 71 | imidazole-containing compound metabolic process (GO:0052803) | 4.34071439 |
| 72 | cellular glucuronidation (GO:0052695) | 4.33261517 |
| 73 | negative regulation of coagulation (GO:0050819) | 4.32300929 |
| 74 | negative regulation of wound healing (GO:0061045) | 4.28880014 |
| 75 | cellular amino acid catabolic process (GO:0009063) | 4.27052010 |
| 76 | alkaloid metabolic process (GO:0009820) | 4.24881886 |
| 77 | cholesterol efflux (GO:0033344) | 4.23593180 |
| 78 | glutamate metabolic process (GO:0006536) | 4.22893227 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 4.18837031 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 4.13648154 |
| 81 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.09455247 |
| 82 | fibrinolysis (GO:0042730) | 4.08479365 |
| 83 | ethanol oxidation (GO:0006069) | 4.07663906 |
| 84 | positive regulation of hemostasis (GO:1900048) | 4.05534445 |
| 85 | positive regulation of blood coagulation (GO:0030194) | 4.05534445 |
| 86 | arginine metabolic process (GO:0006525) | 4.03642052 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 4.02300325 |
| 88 | aldehyde catabolic process (GO:0046185) | 4.01660930 |
| 89 | low-density lipoprotein particle remodeling (GO:0034374) | 4.01543635 |
| 90 | hormone catabolic process (GO:0042447) | 4.00691509 |
| 91 | drug catabolic process (GO:0042737) | 3.98761228 |
| 92 | plasma lipoprotein particle assembly (GO:0034377) | 3.96489990 |
| 93 | serine family amino acid biosynthetic process (GO:0009070) | 3.94404137 |
| 94 | flavonoid metabolic process (GO:0009812) | 3.87452497 |
| 95 | complement activation, classical pathway (GO:0006958) | 3.86973217 |
| 96 | uronic acid metabolic process (GO:0006063) | 3.86501786 |
| 97 | glucuronate metabolic process (GO:0019585) | 3.86501786 |
| 98 | cofactor catabolic process (GO:0051187) | 3.84838777 |
| 99 | complement activation (GO:0006956) | 3.82783140 |
| 100 | negative regulation of lipase activity (GO:0060192) | 3.79535310 |
| 101 | ketone body metabolic process (GO:1902224) | 3.79527483 |
| 102 | negative regulation of complement activation (GO:0045916) | 3.78939881 |
| 103 | cytolysis (GO:0019835) | 3.77534840 |
| 104 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.77249279 |
| 105 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.76794659 |
| 106 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.76794659 |
| 107 | regulation of bile acid biosynthetic process (GO:0070857) | 3.76716554 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 3.74908724 |
| 109 | positive regulation of coagulation (GO:0050820) | 3.73034994 |
| 110 | organic acid catabolic process (GO:0016054) | 3.72990224 |
| 111 | carboxylic acid catabolic process (GO:0046395) | 3.72990224 |
| 112 | phospholipid homeostasis (GO:0055091) | 3.72987630 |
| 113 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.72734499 |
| 114 | response to mercury ion (GO:0046689) | 3.71862911 |
| 115 | cholesterol homeostasis (GO:0042632) | 3.71663590 |
| 116 | * protein activation cascade (GO:0072376) | 3.70792543 |
| 117 | acetyl-CoA metabolic process (GO:0006084) | 3.70540223 |
| 118 | short-chain fatty acid metabolic process (GO:0046459) | 3.66612152 |
| 119 | sterol homeostasis (GO:0055092) | 3.65519867 |
| 120 | opsonization (GO:0008228) | 3.64772207 |
| 121 | intestinal cholesterol absorption (GO:0030299) | 3.64619430 |
| 122 | sodium-independent organic anion transport (GO:0043252) | 3.64230200 |
| 123 | acute inflammatory response (GO:0002526) | 3.62699786 |
| 124 | xenobiotic metabolic process (GO:0006805) | 3.61498006 |
| 125 | NAD biosynthetic process (GO:0009435) | 3.61470055 |
| 126 | plasma lipoprotein particle organization (GO:0071827) | 3.60810221 |
| 127 | acute-phase response (GO:0006953) | 3.57443381 |
| 128 | * blood coagulation, intrinsic pathway (GO:0007597) | 3.56729131 |
| 129 | heme transport (GO:0015886) | 3.56707974 |
| 130 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.55408350 |
| 131 | regulation of acute inflammatory response (GO:0002673) | 3.50294941 |
| 132 | exogenous drug catabolic process (GO:0042738) | 10.9187360 |
| 133 | omega-hydroxylase P450 pathway (GO:0097267) | 10.0056989 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.31220960 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.13776627 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.08922713 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.46103278 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.28495489 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.02900258 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.63141720 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.05626208 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.89495295 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04850186 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8797603 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.87693666 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81221848 |
| 14 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.66338026 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59065296 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.38552880 |
| 17 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38071222 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26946644 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24147901 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17453524 |
| 21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16669809 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06352880 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06118482 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.04461456 |
| 25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98532513 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97953949 |
| 27 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97583329 |
| 28 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.94624121 |
| 29 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.93831149 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91477056 |
| 31 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.89498358 |
| 32 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85754726 |
| 33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.85440811 |
| 34 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84445313 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.84115587 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83278093 |
| 37 | NFYA_21822215_ChIP-Seq_K562_Human | 0.82086945 |
| 38 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.81796643 |
| 39 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.81327015 |
| 40 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80747021 |
| 41 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80648448 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.78727247 |
| 43 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.77771183 |
| 44 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.77692175 |
| 45 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.77691427 |
| 46 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77494618 |
| 47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76605597 |
| 48 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76516702 |
| 49 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72705594 |
| 50 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72705594 |
| 51 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.71897549 |
| 52 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.71471417 |
| 53 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.70908248 |
| 54 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.70182391 |
| 55 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69783607 |
| 56 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69061975 |
| 57 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.66446426 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.66200862 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65912200 |
| 60 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.65798266 |
| 61 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64982465 |
| 62 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.64916862 |
| 63 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.64660391 |
| 64 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.64490723 |
| 65 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.64235184 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.63524035 |
| 67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62919530 |
| 68 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61705054 |
| 69 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.61557904 |
| 70 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60224305 |
| 71 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.60010941 |
| 72 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.59755484 |
| 73 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59063913 |
| 74 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.58274249 |
| 75 | NFYB_21822215_ChIP-Seq_K562_Human | 0.58167250 |
| 76 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57149315 |
| 77 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.56515759 |
| 78 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.55930000 |
| 79 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.55768752 |
| 80 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55499806 |
| 81 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.54159897 |
| 82 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54123198 |
| 83 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.53752642 |
| 84 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.53576499 |
| 85 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52999227 |
| 86 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.52783151 |
| 87 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.52778885 |
| 88 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.52717689 |
| 89 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.52582520 |
| 90 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.52360803 |
| 91 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51904873 |
| 92 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51804623 |
| 93 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.51776080 |
| 94 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51220601 |
| 95 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.50815413 |
| 96 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50713209 |
| 97 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.50212908 |
| 98 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.49879312 |
| 99 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.49178249 |
| 100 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.48775097 |
| 101 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48466291 |
| 102 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.48195608 |
| 103 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.48138769 |
| 104 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.47783199 |
| 105 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.47346406 |
| 106 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46796181 |
| 107 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.46450824 |
| 108 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.46061787 |
| 109 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46038204 |
| 110 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.45844811 |
| 111 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.45668368 |
| 112 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.45591632 |
| 113 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.45264277 |
| 114 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44952657 |
| 115 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.43378696 |
| 116 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.41998184 |
| 117 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.41340738 |
| 118 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.41060554 |
| 119 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.40972777 |
| 120 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40875904 |
| 121 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.40461024 |
| 122 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.39766569 |
| 123 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.38667776 |
| 124 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38576557 |
| 125 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.38526354 |
| 126 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38396809 |
| 127 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.37923623 |
| 128 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.37441247 |
| 129 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.37373138 |
| 130 | NCOR_22424771_ChIP-Seq_293T_Human | 0.37334636 |
| 131 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37315334 |
| 132 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.36890033 |
| 133 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.36606797 |
| 134 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.36405306 |
| 135 | GATA2_19941826_ChIP-Seq_K562_Human | 0.36168855 |
| 136 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.36045836 |
| 137 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.36006059 |
| 138 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35641594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.36820764 |
| 2 | MP0005360_urolithiasis | 7.57144400 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.51647824 |
| 4 | MP0005365_abnormal_bile_salt | 6.20587855 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.21157227 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.24907696 |
| 7 | MP0003252_abnormal_bile_duct | 3.93176443 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.57258548 |
| 9 | MP0009840_abnormal_foam_cell | 3.23903684 |
| 10 | MP0005083_abnormal_biliary_tract | 3.04034425 |
| 11 | MP0003195_calcinosis | 2.82088813 |
| 12 | MP0005332_abnormal_amino_acid | 2.74068617 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.58346861 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.30774505 |
| 15 | MP0000609_abnormal_liver_physiology | 2.14418382 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.13943472 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.09846838 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.00600939 |
| 19 | MP0003868_abnormal_feces_composition | 1.96054320 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.80776364 |
| 21 | MP0001764_abnormal_homeostasis | 1.67363709 |
| 22 | MP0009697_abnormal_copulation | 1.63408689 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55602391 |
| 24 | MP0005451_abnormal_body_composition | 1.46923049 |
| 25 | MP0003011_delayed_dark_adaptation | 1.41347231 |
| 26 | MP0003186_abnormal_redox_activity | 1.22761248 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.20457457 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.19343947 |
| 29 | MP0005647_abnormal_sex_gland | 1.16547771 |
| 30 | MP0000598_abnormal_liver_morphology | 1.14080668 |
| 31 | MP0009764_decreased_sensitivity_to | 1.09179930 |
| 32 | MP0000604_amyloidosis | 1.08531882 |
| 33 | MP0002254_reproductive_system_inflammat | 1.01951579 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.00494310 |
| 35 | * MP0009763_increased_sensitivity_to | 0.97923258 |
| 36 | MP0010368_abnormal_lymphatic_system | 0.93720206 |
| 37 | MP0008469_abnormal_protein_level | 0.90583205 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 0.90541740 |
| 39 | MP0009642_abnormal_blood_homeostasis | 0.86784409 |
| 40 | MP0002282_abnormal_trachea_morphology | 0.84293792 |
| 41 | MP0002876_abnormal_thyroid_physiology | 0.83921581 |
| 42 | MP0005408_hypopigmentation | 0.82448737 |
| 43 | MP0005670_abnormal_white_adipose | 0.82145925 |
| 44 | MP0001915_intracranial_hemorrhage | 0.81478753 |
| 45 | MP0009765_abnormal_xenobiotic_induced | 0.79255167 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 0.78867389 |
| 47 | MP0005376_homeostasis/metabolism_phenot | 0.78857769 |
| 48 | MP0006036_abnormal_mitochondrial_physio | 0.78434850 |
| 49 | MP0002078_abnormal_glucose_homeostasis | 0.75976639 |
| 50 | MP0005187_abnormal_penis_morphology | 0.74854728 |
| 51 | MP0003690_abnormal_glial_cell | 0.74106026 |
| 52 | MP0001661_extended_life_span | 0.71656051 |
| 53 | MP0002971_abnormal_brown_adipose | 0.71197349 |
| 54 | MP0005220_abnormal_exocrine_pancreas | 0.69819162 |
| 55 | MP0005535_abnormal_body_temperature | 0.69553622 |
| 56 | MP0004130_abnormal_muscle_cell | 0.67678108 |
| 57 | MP0005334_abnormal_fat_pad | 0.67561269 |
| 58 | MP0003329_amyloid_beta_deposits | 0.63036459 |
| 59 | MP0005023_abnormal_wound_healing | 0.62691828 |
| 60 | MP0005266_abnormal_metabolism | 0.62505348 |
| 61 | MP0009053_abnormal_anal_canal | 0.62257662 |
| 62 | MP0002249_abnormal_larynx_morphology | 0.62145746 |
| 63 | MP0000639_abnormal_adrenal_gland | 0.60204952 |
| 64 | MP0003879_abnormal_hair_cell | 0.56585191 |
| 65 | MP0006035_abnormal_mitochondrial_morpho | 0.54723574 |
| 66 | MP0005448_abnormal_energy_balance | 0.54590271 |
| 67 | MP0009785_altered_susceptibility_to | 0.54071345 |
| 68 | MP0001756_abnormal_urination | 0.53388584 |
| 69 | MP0005464_abnormal_platelet_physiology | 0.51849722 |
| 70 | MP0002822_catalepsy | 0.50744461 |
| 71 | MP0004381_abnormal_hair_follicle | 0.50439170 |
| 72 | MP0008874_decreased_physiological_sensi | 0.49513936 |
| 73 | MP0003724_increased_susceptibility_to | 0.47928764 |
| 74 | MP0005395_other_phenotype | 0.47917955 |
| 75 | MP0003718_maternal_effect | 0.46661998 |
| 76 | MP0003638_abnormal_response/metabolism_ | 0.46404376 |
| 77 | MP0002928_abnormal_bile_duct | 0.44792269 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 0.44375329 |
| 79 | MP0008873_increased_physiological_sensi | 0.43698399 |
| 80 | MP0005248_abnormal_Harderian_gland | 0.43314571 |
| 81 | MP0002332_abnormal_exercise_endurance | 0.42936917 |
| 82 | MP0003436_decreased_susceptibility_to | 0.42868497 |
| 83 | MP0002136_abnormal_kidney_physiology | 0.42436782 |
| 84 | MP0003953_abnormal_hormone_level | 0.39601830 |
| 85 | MP0002837_dystrophic_cardiac_calcinosis | 0.39415679 |
| 86 | MP0008872_abnormal_physiological_respon | 0.39085011 |
| 87 | MP0003075_altered_response_to | 0.38456617 |
| 88 | MP0000579_abnormal_nail_morphology | 0.37864019 |
| 89 | MP0005166_decreased_susceptibility_to | 0.37480339 |
| 90 | MP0006082_CNS_inflammation | 0.35403792 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.32740165 |
| 92 | MP0000467_abnormal_esophagus_morphology | 0.32379336 |
| 93 | MP0001545_abnormal_hematopoietic_system | 0.31605541 |
| 94 | MP0005397_hematopoietic_system_phenotyp | 0.31605541 |
| 95 | MP0009115_abnormal_fat_cell | 0.31170415 |
| 96 | MP0009384_cardiac_valve_regurgitation | 0.31100686 |
| 97 | MP0001853_heart_inflammation | 0.31068027 |
| 98 | MP0009672_abnormal_birth_weight | 0.30874827 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.30814769 |
| 100 | MP0002796_impaired_skin_barrier | 0.30654671 |
| 101 | MP0000249_abnormal_blood_vessel | 0.30560902 |
| 102 | MP0004883_abnormal_blood_vessel | 0.29534211 |
| 103 | MP0002168_other_aberrant_phenotype | 0.29069795 |
| 104 | MP0000566_synostosis | 0.29049722 |
| 105 | MP0001851_eye_inflammation | 0.28892252 |
| 106 | MP0001881_abnormal_mammary_gland | 0.28124676 |
| 107 | MP0001243_abnormal_dermal_layer | 0.27922329 |
| 108 | MP0001845_abnormal_inflammatory_respons | 0.27328214 |
| 109 | MP0002970_abnormal_white_adipose | 0.26382855 |
| 110 | MP0002090_abnormal_vision | 0.25803048 |
| 111 | MP0002132_abnormal_respiratory_system | 0.25278694 |
| 112 | MP0005164_abnormal_response_to | 0.24987761 |
| 113 | MP0000427_abnormal_hair_cycle | 0.23751797 |
| 114 | MP0003959_abnormal_lean_body | 0.22482747 |
| 115 | MP0004142_abnormal_muscle_tone | 0.19828107 |
| 116 | MP0005197_abnormal_uvea_morphology | 0.18298671 |
| 117 | MP0001944_abnormal_pancreas_morphology | 0.17285618 |
| 118 | MP0005058_abnormal_lysosome_morphology | 0.17239808 |
| 119 | MP0003633_abnormal_nervous_system | 0.16521221 |
| 120 | MP0003632_abnormal_nervous_system | 0.16432388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.47052897 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.45404916 |
| 3 | * Deep venous thrombosis (HP:0002625) | 6.99311374 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.76094428 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.54659269 |
| 6 | Xanthomatosis (HP:0000991) | 6.31799709 |
| 7 | * Prolonged partial thromboplastin time (HP:0003645) | 6.29837763 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.69197907 |
| 9 | Complement deficiency (HP:0004431) | 5.65119167 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.84828131 |
| 11 | Hyperammonemia (HP:0001987) | 4.60858458 |
| 12 | Epidermoid cyst (HP:0200040) | 4.60706971 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.56996436 |
| 14 | Hyperglycinemia (HP:0002154) | 4.45819948 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.45327970 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 4.35017272 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26816054 |
| 18 | * Joint hemorrhage (HP:0005261) | 4.23833604 |
| 19 | Ketosis (HP:0001946) | 4.23268193 |
| 20 | Fat malabsorption (HP:0002630) | 4.22758602 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 4.18991014 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.18358279 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.15586333 |
| 24 | Abnormality of complement system (HP:0005339) | 4.11102318 |
| 25 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.93631683 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90031128 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.90031128 |
| 28 | Hyperglycinuria (HP:0003108) | 3.89488422 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.86232686 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.77440097 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.65228492 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.34475362 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.34276823 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.27517697 |
| 35 | Steatorrhea (HP:0002570) | 3.22153092 |
| 36 | Spontaneous abortion (HP:0005268) | 3.16825128 |
| 37 | * Abnormality of the intrinsic pathway (HP:0010989) | 3.15058087 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 3.11626927 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.08615789 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06916482 |
| 41 | Hypochromic microcytic anemia (HP:0004840) | 3.01642677 |
| 42 | Ketoacidosis (HP:0001993) | 2.97482284 |
| 43 | Myocardial infarction (HP:0001658) | 2.97292535 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.95267798 |
| 45 | Osteomalacia (HP:0002749) | 2.93422527 |
| 46 | Neonatal hypoglycemia (HP:0001998) | 2.88020244 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 2.84857361 |
| 48 | Skin nodule (HP:0200036) | 2.82874214 |
| 49 | Metabolic acidosis (HP:0001942) | 2.74844613 |
| 50 | Fair hair (HP:0002286) | 2.68802803 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.63558882 |
| 52 | Lethargy (HP:0001254) | 2.63070490 |
| 53 | Vascular calcification (HP:0004934) | 2.61974517 |
| 54 | Glomerulonephritis (HP:0000099) | 2.58984311 |
| 55 | Acanthocytosis (HP:0001927) | 2.56398019 |
| 56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.54749244 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.51370846 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.51370846 |
| 59 | Cerebral edema (HP:0002181) | 2.48727327 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 2.48260668 |
| 61 | Hypoglycemic seizures (HP:0002173) | 2.46428257 |
| 62 | Spastic diplegia (HP:0001264) | 2.44836968 |
| 63 | Mitral stenosis (HP:0001718) | 2.44625592 |
| 64 | Purpura (HP:0000979) | 2.42251675 |
| 65 | Cholelithiasis (HP:0001081) | 2.40949724 |
| 66 | Abnormal gallbladder physiology (HP:0012438) | 2.39391959 |
| 67 | Cholecystitis (HP:0001082) | 2.39391959 |
| 68 | Irritability (HP:0000737) | 2.37102987 |
| 69 | Neonatal onset (HP:0003623) | 2.34881867 |
| 70 | Amyloidosis (HP:0011034) | 2.34868469 |
| 71 | Gout (HP:0001997) | 2.32976686 |
| 72 | Cardiovascular calcification (HP:0011915) | 2.31212634 |
| 73 | Gingival bleeding (HP:0000225) | 2.30642564 |
| 74 | Malnutrition (HP:0004395) | 2.21498405 |
| 75 | Menorrhagia (HP:0000132) | 2.21427941 |
| 76 | Esophageal varix (HP:0002040) | 2.18097411 |
| 77 | Sensorimotor neuropathy (HP:0007141) | 2.15684084 |
| 78 | Pancreatitis (HP:0001733) | 2.15281741 |
| 79 | Joint swelling (HP:0001386) | 2.14224241 |
| 80 | Enlarged kidneys (HP:0000105) | 2.13549223 |
| 81 | Elevated alkaline phosphatase (HP:0003155) | 2.13345600 |
| 82 | Brushfield spots (HP:0001088) | 2.11539661 |
| 83 | Thrombophlebitis (HP:0004418) | 2.11530881 |
| 84 | Hyperphosphaturia (HP:0003109) | 2.10577053 |
| 85 | Late onset (HP:0003584) | 2.07840168 |
| 86 | Vomiting (HP:0002013) | 2.05980481 |
| 87 | Opisthotonus (HP:0002179) | 2.05792772 |
| 88 | Reduced antithrombin III activity (HP:0001976) | 2.01820189 |
| 89 | Abnormality of the gallbladder (HP:0005264) | 2.01290061 |
| 90 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.00282578 |
| 91 | Poikilocytosis (HP:0004447) | 1.98505116 |
| 92 | Hemorrhage of the eye (HP:0011885) | 1.98055927 |
| 93 | Rickets (HP:0002748) | 1.96757998 |
| 94 | Hypophosphatemic rickets (HP:0004912) | 1.94564052 |
| 95 | Generalized aminoaciduria (HP:0002909) | 1.93368599 |
| 96 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.93306842 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 1.93223775 |
| 98 | Arthropathy (HP:0003040) | 1.91033887 |
| 99 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89158681 |
| 100 | Renal cortical cysts (HP:0000803) | 1.88927581 |
| 101 | Generalized hypopigmentation of hair (HP:0011358) | 1.88385034 |
| 102 | Abnormality of urine glucose concentration (HP:0011016) | 1.88088874 |
| 103 | Glycosuria (HP:0003076) | 1.88088874 |
| 104 | Increased serum ferritin (HP:0003281) | 1.87399793 |
| 105 | Status epilepticus (HP:0002133) | 1.86850904 |
| 106 | Increased mean platelet volume (HP:0011877) | 1.86175180 |
| 107 | Epistaxis (HP:0000421) | 1.85452626 |
| 108 | Alkalosis (HP:0001948) | 1.85274974 |
| 109 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83656935 |
| 110 | Elevated hepatic transaminases (HP:0002910) | 1.82264376 |
| 111 | Abnormality of proline metabolism (HP:0010907) | 1.81684901 |
| 112 | Hydroxyprolinuria (HP:0003080) | 1.81684901 |
| 113 | Nephritis (HP:0000123) | 1.81585996 |
| 114 | Abnormal cartilage morphology (HP:0002763) | 1.80529804 |
| 115 | Bifid scrotum (HP:0000048) | 1.78446613 |
| 116 | Abnormality of vitamin metabolism (HP:0100508) | 1.77440013 |
| 117 | Cerebral palsy (HP:0100021) | 1.73140361 |
| 118 | Pulmonary embolism (HP:0002204) | 1.71906000 |
| 119 | Abnormal platelet volume (HP:0011876) | 1.68931601 |
| 120 | Bile duct proliferation (HP:0001408) | 1.67979981 |
| 121 | Abnormal biliary tract physiology (HP:0012439) | 1.67979981 |
| 122 | Abnormality of the Achilles tendon (HP:0005109) | 1.67432540 |
| 123 | Gangrene (HP:0100758) | 1.67176461 |
| 124 | Abnormal urine phosphate concentration (HP:0012599) | 1.66850440 |
| 125 | Blue irides (HP:0000635) | 1.66632265 |
| 126 | Abnormal delivery (HP:0001787) | 1.65528834 |
| 127 | Impaired platelet aggregation (HP:0003540) | 1.57217491 |
| 128 | Abnormal platelet function (HP:0011869) | 1.57217491 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.08464933 |
| 2 | FGFR4 | 4.56524179 |
| 3 | SIK1 | 4.44900861 |
| 4 | ERN1 | 4.20557385 |
| 5 | TAOK3 | 3.25792239 |
| 6 | INSRR | 3.19893178 |
| 7 | ERBB4 | 3.15872068 |
| 8 | MAP2K4 | 2.45545704 |
| 9 | MST1R | 2.16586629 |
| 10 | PRPF4B | 2.13977780 |
| 11 | PIK3CG | 1.92050372 |
| 12 | MAPK11 | 1.88281232 |
| 13 | PKN2 | 1.81481898 |
| 14 | NLK | 1.75639934 |
| 15 | FLT3 | 1.69739867 |
| 16 | TYK2 | 1.69624825 |
| 17 | DAPK2 | 1.67018089 |
| 18 | NTRK3 | 1.61546423 |
| 19 | LATS1 | 1.59945311 |
| 20 | ABL2 | 1.52232838 |
| 21 | FGFR2 | 1.50720222 |
| 22 | TNK2 | 1.42699288 |
| 23 | NEK9 | 1.41060259 |
| 24 | PTK6 | 1.35016056 |
| 25 | CAMKK2 | 1.32843456 |
| 26 | FRK | 1.31806121 |
| 27 | FER | 1.31314989 |
| 28 | MAP3K14 | 1.27157345 |
| 29 | TRIB3 | 1.26480607 |
| 30 | MAP3K7 | 1.24440819 |
| 31 | MAP3K2 | 1.23511903 |
| 32 | JAK2 | 1.22716221 |
| 33 | KDR | 1.19292035 |
| 34 | PINK1 | 1.17409178 |
| 35 | PRKAA2 | 1.15398588 |
| 36 | JAK1 | 1.06221904 |
| 37 | GRK6 | 1.05448310 |
| 38 | TBK1 | 1.04289678 |
| 39 | MAPK4 | 1.02326570 |
| 40 | MAP3K1 | 1.01414559 |
| 41 | ERBB2 | 1.01156925 |
| 42 | PRKCZ | 0.98259323 |
| 43 | PRKG1 | 0.94716947 |
| 44 | MAPK15 | 0.90862317 |
| 45 | EPHB1 | 0.89481701 |
| 46 | MAP2K3 | 0.89388230 |
| 47 | MAPK12 | 0.88928541 |
| 48 | MYLK | 0.85239899 |
| 49 | MET | 0.81763770 |
| 50 | CAMK2G | 0.81257772 |
| 51 | KSR2 | 0.80610479 |
| 52 | TIE1 | 0.79034127 |
| 53 | IRAK3 | 0.78597416 |
| 54 | PRKACG | 0.78470331 |
| 55 | SCYL2 | 0.78186558 |
| 56 | EPHA3 | 0.77534068 |
| 57 | CSK | 0.77319780 |
| 58 | STK38L | 0.76566826 |
| 59 | MAP3K10 | 0.75410517 |
| 60 | EPHA4 | 0.74700895 |
| 61 | MAPK7 | 0.71641692 |
| 62 | MAP3K3 | 0.69923092 |
| 63 | MAP2K6 | 0.69245799 |
| 64 | PKN1 | 0.68854208 |
| 65 | CDK6 | 0.68321331 |
| 66 | GRK1 | 0.67305171 |
| 67 | MAP3K11 | 0.66888201 |
| 68 | GSK3A | 0.65961830 |
| 69 | ZAP70 | 0.65020511 |
| 70 | CAMK1D | 0.64634913 |
| 71 | PRKCQ | 0.63408688 |
| 72 | MAP3K13 | 0.63326735 |
| 73 | CAMKK1 | 0.63184849 |
| 74 | PRKAA1 | 0.61558764 |
| 75 | TGFBR2 | 0.59800122 |
| 76 | PBK | 0.59075904 |
| 77 | SGK3 | 0.58730596 |
| 78 | IKBKE | 0.58653348 |
| 79 | CSF1R | 0.58558456 |
| 80 | DYRK1B | 0.58388506 |
| 81 | PRKCB | 0.57054716 |
| 82 | WNK3 | 0.56717578 |
| 83 | CSNK1D | 0.56216771 |
| 84 | BRSK2 | 0.55141996 |
| 85 | PRKACB | 0.54638465 |
| 86 | TAOK2 | 0.54578219 |
| 87 | RPS6KA3 | 0.54414239 |
| 88 | CSNK1G1 | 0.54259776 |
| 89 | PDPK1 | 0.53702443 |
| 90 | ARAF | 0.53266351 |
| 91 | CSNK1E | 0.52796918 |
| 92 | FGFR3 | 0.50031846 |
| 93 | PRKCG | 0.49749350 |
| 94 | SGK2 | 0.48498992 |
| 95 | PTK2 | 0.48443401 |
| 96 | BLK | 0.48413697 |
| 97 | IGF1R | 0.47925485 |
| 98 | MAP3K5 | 0.44295268 |
| 99 | MAP3K9 | 0.42557701 |
| 100 | IRAK1 | 0.41540015 |
| 101 | MAP2K1 | 0.41108433 |
| 102 | SRC | 0.40747458 |
| 103 | IRAK2 | 0.40275658 |
| 104 | RIPK1 | 0.39539828 |
| 105 | SGK1 | 0.37845913 |
| 106 | MAP3K12 | 0.36479213 |
| 107 | ICK | 0.36456680 |
| 108 | SGK223 | 0.36159620 |
| 109 | SGK494 | 0.36159620 |
| 110 | PIK3CA | 0.35901790 |
| 111 | RET | 0.35136386 |
| 112 | CSNK1G2 | 0.34601588 |
| 113 | MAP3K6 | 0.33493079 |
| 114 | CSNK2A1 | 0.33289367 |
| 115 | EGFR | 0.33265527 |
| 116 | PDK1 | 0.32504484 |
| 117 | CSNK1G3 | 0.32099330 |
| 118 | PRKCA | 0.29592151 |
| 119 | CAMK4 | 0.29344861 |
| 120 | CDK4 | 0.28268927 |
| 121 | PAK3 | 0.27282453 |
| 122 | CAMK1G | 0.26236691 |
| 123 | ABL1 | 0.25500021 |
| 124 | CSNK1A1L | 0.23834037 |
| 125 | MTOR | 0.22864279 |
| 126 | AKT3 | 0.21540543 |
| 127 | PRKACA | 0.20749887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.59808087 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.56492746 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.42616776 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36070539 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07977678 |
| 6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.77543168 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72251383 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70518722 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.57051713 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52840249 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43628425 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36180283 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26194604 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.18636243 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13344806 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.08195215 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.00595198 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.98662408 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.96844598 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93112316 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91081721 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.85721885 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85483732 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.82364221 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77379403 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76572797 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.75799652 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74034411 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71596627 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68404585 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58353750 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58104006 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52270186 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51370132 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.48386005 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46116372 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43840459 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35872901 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33087043 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32974679 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29628814 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28245793 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21349863 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.20542467 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17860816 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15699349 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13758728 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09786978 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07182610 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99797448 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96887191 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95904142 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93703117 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92485125 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89357488 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88893777 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84764906 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79911816 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.78358325 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71674830 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65913556 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65692072 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63247125 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52998192 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52640206 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45955699 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.41200225 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40724041 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38327583 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25661288 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24745887 |
| 72 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21427349 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20855362 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20339223 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.19878266 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19584676 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15931599 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08314983 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.02564367 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2780278 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2661154 |
| 82 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2489955 |
| 83 | Pertussis_Homo sapiens_hsa05133 | -0.2458269 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2447483 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | -0.2350969 |
| 86 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2345788 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2211208 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2136011 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2108266 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2068743 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2007865 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1981231 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1890507 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1807878 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1743467 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1636482 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1529402 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1432632 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1407236 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1260910 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1246721 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1148361 |
| 103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1043424 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | -0.0987330 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0765969 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0511706 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0275692 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0013730 |

